As displayed in Figure 2, the ability of serum neuritin levels in prognosticating poor prognosis was equivalent to those of GCS scores (AUC, 0.807; 95% CI, 0.745–0.859; p = 0.408) and hematoma volume (AUC, 0.801; 95% CI, 0.739–0.854; p = 0.451). The gene discussed is NRN1; the disease is hematoma.